Cargando…
Pediatric Safety of Polysorbates in Drug Formulations
Polysorbates 20 and 80 are the most frequently used excipients in biotherapeutics, the safety data for which have been well documented in adults. The polysorbate content in therapeutic formulations that are administered to children, however, has been less clearly regulated or defined with regard to...
Autores principales: | Kriegel, Christina, Festag, Matthias, Kishore, Ravuri S.K., Roethlisberger, Dieter, Schmitt, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022221/ https://www.ncbi.nlm.nih.gov/pubmed/31877624 http://dx.doi.org/10.3390/children7010001 |
Ejemplares similares
-
Safety of Polysorbate 80 in the Oncology Setting
por: Schwartzberg, Lee S., et al.
Publicado: (2018) -
Protein Formulations Containing Polysorbates: Are Metal Chelators Needed at All?
por: Brovč, Ema Valentina, et al.
Publicado: (2020) -
The effect of polysorbate 20 and polysorbate 80 on the solubility of quercetin
por: Erawati, Tristiana, et al.
Publicado: (2023) -
Effect of Fatty Acid Composition in Polysorbate 80 on the Stability of Therapeutic Protein Formulations
por: Pegues, Melissa A., et al.
Publicado: (2021) -
Formulation and Characterization of Epalrestat-Loaded Polysorbate 60 Cationic Niosomes for Ocular Delivery
por: Kattar, Axel, et al.
Publicado: (2023)